F.D.A. Approves a Drug for Late-Stage Pancreatic Cancer
Friday, September 6, 2013 - 23:40
in Health & Medicine
The Food and Drug Administration has approved Abraxane, which in a clinical trial prolonged the lives of patients by a little less than two months on average.